BACE1 and Alzheimer disease: More recently, Tang et al. found increased levels of Aβ, increased immunoreactivity of BACE1, and decreased immunoreactivity of ADAM10 in platelets of AD, indicating that the amyloidogenic pathway of the APP metabolism is activated in platelets of AD patients, paralleling the intracerebral APP processing in AD [4].